Literature DB >> 23805355

Non-viral factors contributing to hepatocellular carcinoma.

Manal A Hamed1, Sanaa A Ali.   

Abstract

Hepatocellular carcinoma (HCC) is a major cause of cancer death worldwide, accounting for over half a million deaths per year. The geographic pattern of HCC incidence is parallel to exposure to viral etiologic factors. Its incidence is increasing, ranging between 3% and 9% annually depending on the geographical location, and variability in the incidence rates correspond closely to the prevalence and pattern of the primary etiologic factors. Chronic infections with hepatitis B viruses or hepatitis C viruses have both been recognized as human liver carcinogens with a combined attributable fraction of at least 75% of all HCC cases. Multiple non-viral factors have been implicated in the development of HCC. Increased body mass index and diabetes with subsequent development of non-alcoholic steatohepatitis represent significant risk factors for HCC. Other non-viral causes of HCC include iron overload syndromes, alcohol use, tobacco, oral contraceptive, aflatoxin, pesticides exposure and betel quid chewing, a prevalent habit in the developing world. Wilson disease, α-1 antitrypsin deficiency, Porphyrias, autoimmune hepatitis, Schistosoma japonicum associated with positive hepatitis B surface antigen, and thorotrast-ray are also contributing hepatocellualar carcinoma. In addition, primary biliary cirrhosis, congestive liver disease and family history of liver cancer increase the risk of HCC incident. In conclusion, clarification of relevant non-viral causes of HCC will help to focus clinicians on those risk factors that are modifiable. The multilevel preventative approach will hopefully lead to a reduction in incidence of non-viral HCC, and a decrease in the patient morbidity and mortality as well as the societal economic burden associated with HCC.

Entities:  

Keywords:  Hepatocellular carcinoma; Non viral factors; Viral etiologic factors

Year:  2013        PMID: 23805355      PMCID: PMC3692972          DOI: 10.4254/wjh.v5.i6.311

Source DB:  PubMed          Journal:  World J Hepatol


  99 in total

Review 1.  Coffee and cancer risk: an update.

Authors:  Carlo La Vecchia; Alessandra Tavani
Journal:  Eur J Cancer Prev       Date:  2007-10       Impact factor: 2.497

2.  Geographic variation of p53 mutational profile in nonmalignant human liver.

Authors:  F Aguilar; C C Harris; T Sun; M Hollstein; P Cerutti
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

3.  Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region.

Authors:  T Mizoue; N Tokui; K Nishisaka; S Nishisaka; I Ogimoto; M Ikeda; T Yoshimura
Journal:  Int J Epidemiol       Date:  2000-04       Impact factor: 7.196

Review 4.  Haemochromatosis in the new millennium.

Authors:  L W Powell; V N Subramaniam; T R Yapp
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Obesity and cancer risk: a Danish record-linkage study.

Authors:  H Møller; A Mellemgaard; K Lindvig; J H Olsen
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

7.  Liver cell adenoma with malignant transformation: a case report.

Authors:  Masahiro Ito; Makoto Sasaki; Chun Yang Wen; Masahiro Nakashima; Toshihito Ueki; Hiromi Ishibashi; Michitami Yano; Masayoshi Kage; Masamichi Kojiro
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

8.  Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma.

Authors:  Masahiro Munaka; Kiyotaka Kohshi; Toshihiro Kawamoto; Shin Takasawa; Naoki Nagata; Hideaki Itoh; Susumu Oda; Takahiko Katoh
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-21       Impact factor: 4.553

9.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.

Authors:  G S Qian; R K Ross; M C Yu; J M Yuan; Y T Gao; B E Henderson; G N Wogan; J D Groopman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Jan-Feb       Impact factor: 4.254

Review 10.  Non-viral causes of hepatocellular carcinoma.

Authors:  David H Van Thiel; Guiliano Ramadori
Journal:  J Gastrointest Cancer       Date:  2011-12
View more
  23 in total

1.  Hepatocellular carcinoma with extension to the heart via the inferior vena cava.

Authors:  Melody Oncale; Brian Lewis
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-04

2.  Virtual iron concentration imaging based on dual-energy CT for noninvasive quantification and grading of liver iron content: An iron overload rabbit model study.

Authors:  Xian Fu Luo; Yi Yang; Jing Yan; Xue Qian Xie; Huan Zhang; Wei Min Chai; Li Wang; Bernhard Schmidt; Fu Hua Yan
Journal:  Eur Radiol       Date:  2015-03-15       Impact factor: 5.315

3.  Modeling the Trend Changes of Liver Cancer Mortality in the 6 WHO Regions.

Authors:  Seyedeh Fatemeh Musavi Ezmareh; Kamran Mehrabani; Hadi Raeisi Shahraki
Journal:  Turk J Gastroenterol       Date:  2022-06       Impact factor: 1.555

Review 4.  Hepatitis B among Asian Americans: Prevalence, progress, and prospects for control.

Authors:  Moon S Chen; Julie Dang
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

5.  Population attributable fractions of risk factors for hepatocellular carcinoma in the United States.

Authors:  Oxana V Makarova-Rusher; Sean F Altekruse; Tim S McNeel; Susanna Ulahannan; Austin G Duffy; Barry I Graubard; Tim F Greten; Katherine A McGlynn
Journal:  Cancer       Date:  2016-03-21       Impact factor: 6.860

6.  Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.

Authors:  Sean F Altekruse; S Jane Henley; James E Cucinelli; Katherine A McGlynn
Journal:  Am J Gastroenterol       Date:  2014-02-11       Impact factor: 10.864

7.  Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma.

Authors:  S Karabulut; F Tas; F Akyüz; A C Ormeci; M Serilmez; H O Soydinç; S Vatansever; V Yasasever
Journal:  Tumour Biol       Date:  2013-10-20

8.  Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma.

Authors:  S Karabulut; D Duranyıldız; F Tas; U Gezer; F Akyüz; M Serilmez; E Ozgür; C T Yasasever; S Vatansever; N F Aykan
Journal:  Tumour Biol       Date:  2013-11-23

9.  Genetic polymorphism of the human organic solute carrier protein 1 (hOSCP1) gene in Japanese patients with non-viral liver carcinoma.

Authors:  Mayumi Toda; Yasuna Kobayashi; Tomotake Koizumi; Koji Saito; Masayuki Ohbayashi; Noriko Kohyama; Takeshi Aoki; Masahiko Murakami; Hajime Yasuhara; Toshinori Yamamoto
Journal:  Meta Gene       Date:  2014-10-01

10.  Molecular characterization of severin from Clonorchis sinensis excretory/secretory products and its potential anti-apoptotic role in hepatocarcinoma PLC cells.

Authors:  Xueqing Chen; Shan Li; Lei He; Xiaoyun Wang; Pei Liang; Wenjun Chen; Meng Bian; Mengyu Ren; Jinsi Lin; Chi Liang; Jin Xu; Zhongdao Wu; Xuerong Li; Yan Huang; Xinbing Yu
Journal:  PLoS Negl Trop Dis       Date:  2013-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.